Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis--a longitudinal study. - Wikidata - awgldk - TriplyDB

Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis--a longitudinal study.

Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis--a longitudinal study.

http://www.wikidata.org/entity/Q34702127

about

Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents Gut Microbiota and Host Reaction in Liver Diseases What are the effects of proton pump inhibitors on the small intestine?Asian consensus on the relationship between obesity and gastrointestinal and liver diseases.Fructo-oligosaccharides and intestinal barrier function in a methionine-choline-deficient mouse model of nonalcoholic steatohepatitis.Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review.Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.Determining microbial products and identifying molecular targets in the human microbiome.The gut microbiota of Colombians differs from that of Americans, Europeans and Asians.The gut microbiota and the liver: implications for clinical practice.Meta-omic platforms to assist in the understanding of NAFLD gut microbiota alterations: tools and applications.The relevance of intestinal dysbiosis in liver transplant candidates.Effects of high doses of vitamin D3 on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tract.Perilipin-2 Modulates Lipid Absorption and Microbiome Responses in the Mouse Intestine.Gut-liver axis, nutrition, and non-alcoholic fatty liver disease Influence of gut bacteria on development and progression of non-alcoholic fatty liver disease.Combining metagenomics, metatranscriptomics and viromics to explore novel microbial interactions: towards a systems-level understanding of human microbiome.Lactobacillus casei Shirota Supplementation Does Not Restore Gut Microbiota Composition and Gut Barrier in Metabolic Syndrome: A Randomized Pilot Study.The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol Prevention of antibiotic-associated metabolic syndrome in mice by intestinal alkaline phosphatase Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis.Non-alcoholic fatty liver and the gut microbiota.Intestinal Dysbiosis Is Associated with Altered Short-Chain Fatty Acids and Serum-Free Fatty Acids in Systemic Lupus Erythematosus Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease.Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.Gut Microbiota of Nonalcoholic Fatty Liver Disease.Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.Gut microbiome and liver disease.The gut microbiome composition associates with bipolar disorder and illness severity.Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet.Gut Microbiota: Association with NAFLD and Metabolic Disturbances.Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.Nutrikinetic study of genistein metabolites in ovariectomized mice.Flos Lonicera Combined with Metformin Ameliorates Hepatosteatosis and Glucose Intolerance in Association with Gut Microbiota Modulation.Meta-analysis of gut microbiome studies identifies disease-specific and shared responses.Deletion of both p62 and Nrf2 spontaneously results in the development of nonalcoholic steatohepatitis.Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis.

P2860

Q26752614-BCAE9E63-6014-4D2F-B763-EE6E4653DE44 Q26753047-A5A5B417-490A-4E04-9461-92628681F679 Q26772302-79BC2E40-1F54-4A49-B03F-A9D8B1B5572B Q28083295-D7BE797A-759B-4754-B9C5-95B5AC43ED22 Q28263539-178675B4-0178-449A-B990-4D36F048AC38 Q30251719-DC307326-4F44-4E7E-8A65-ACFDA3C785F7 Q33817253-E6147FC0-0F8F-4ED0-A732-E7E176574F15 Q34144918-4EE432AB-863C-4A05-87D9-527FAE1E2CD3 Q34499017-48A76DCD-4F7E-49BA-8F62-4C87DECF6992 Q34625923-BFB9E9BC-EECE-4B0B-AC12-8A8D3DCC8B5B Q34768911-67724A34-1B46-4DF2-8801-36483E29C96A Q35019661-0ADBBE08-0E86-46C7-B44D-F2CFBFBDFC96 Q35084719-C8012CDC-9138-4440-A37E-DD7D786AEE03 Q35569791-243E8F37-CB13-4945-B3CE-0FCCB3C6EB31 Q35679288-A49D0532-0221-4A6D-A0FA-72B90A8D448B Q35683242-E853AF7C-642A-4622-AD33-1E778CF4E8A1 Q35685083-A8A22FE3-F5BF-4E33-9191-CA135243E4FA Q35790409-D8F0C8E6-5FC5-4C34-99CF-36DFED297C7F Q35794069-E1CB774E-8AD2-4A0F-A942-7174A4C3FFCA Q35824398-26F882FB-5B52-436E-92DF-2A156362419D Q35850620-F9B16C22-1E7D-45B6-9D29-C1B803B254DC Q35860576-9DF4F447-3140-48A8-BA45-2D0B1601CE70 Q35923655-67C2EF3F-2A3A-4613-AB39-F19ECBF22688 Q36740555-94AE564B-B5AF-4028-9F8E-C497CD7E36DD Q37215934-98346010-05B2-4BEA-BFB5-8854663AA727 Q37598434-359EECBB-477D-4CCC-A5A7-D995036E83B6 Q38298751-F933A404-59FB-4FCE-8F40-139DEE9B8475 Q38397177-55D918C6-4E13-4AA3-AD7D-1BAC0242672A Q38742769-0CB754FC-3129-47A6-9DAC-A837693319CD Q38865456-9A9DEBDF-83AE-4214-BCC1-8EB68B1E3EE9 Q38914215-8484FA2D-2EE6-4A24-B8CD-B92913B2C799 Q39092287-F2C4E88C-088D-4A6F-9539-18F67749611A Q39180593-B29D2311-26D1-425B-9CD8-AE66C5F27546 Q41564230-5C3701A3-D8B9-426E-BD34-54E71CE6B1C2 Q42000430-C39E0DCA-70BF-4E6A-9F45-33C8889367F3 Q42994335-AAD7E7D2-533D-4D3E-A948-EB86898800A1 Q46222234-985963FF-7826-470A-A3AA-96D72F73B61D Q46247318-67A08AFA-A252-461A-96EB-3944E2B48AAC Q47256841-0970F218-B64A-45D4-83D6-17FCD4DBC387 Q47430306-0874FC97-173F-432F-9487-5CD91C5EFF72

P2860

Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis--a longitudinal study.

http://www.wikidata.org/entity/Q34702127

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Molecular characterization of ...... patitis--a longitudinal study.

@ast

Molecular characterization of ...... patitis--a longitudinal study.

@en

Molecular characterization of ...... patitis--a longitudinal study.

@nl

type

label

Molecular characterization of ...... patitis--a longitudinal study.

@ast

Molecular characterization of ...... patitis--a longitudinal study.

@en

Molecular characterization of ...... patitis--a longitudinal study.

@nl

prefLabel

Molecular characterization of ...... patitis--a longitudinal study.

@ast

Molecular characterization of ...... patitis--a longitudinal study.

@en

Molecular characterization of ...... patitis--a longitudinal study.

@nl

P1433

Q34702127-734F2DD4-A356-4F8A-AD65-405A5FA01078

P1476

Q34702127-1342BACA-41A2-4506-B6C3-195D0E9F6D5F

P2093

Q34702127-4CA23941-A474-47FA-A365-F528F05A6863

Q34702127-6335E5B3-76B3-4FF5-AD77-37917BEE51EA

Q34702127-897A9E1E-C016-42A3-BCA3-5EC544C96CB1

Q34702127-BAD73350-27FE-4B09-B851-555320888CAE

Q34702127-CA856A98-2698-44E2-8E84-32FFEA8D2661

P2860

Q34702127-13888C17-A866-4716-871A-395B27EEE72E

Q34702127-1A871666-1F6D-48EE-B705-956B2BBC6BBA

Q34702127-1EBEB648-0192-4D1A-89A2-CE56C73F55C4

Q34702127-20677D5B-5A1A-4CB8-939F-5FD061008C22

Q34702127-25205B4A-FE58-4D3D-A302-C1936FB0DF89

Q34702127-2F4F10EB-0C27-4B97-96CC-21A327A42898

Q34702127-2FEDE45F-426F-4F1C-9DA1-75F6F77D5FB1

Q34702127-31A47191-D64C-4438-A743-7220C5BB2F20

Q34702127-327161E7-C2BF-4E4F-B410-D12C88F618BB

Q34702127-32D9B4EE-08BB-40C9-A5B9-FBF1F13DC670

P304

Q34702127-9C8F7C04-A3A8-4F48-9606-552DB38F4E6C

P31

Q34702127-A0A4B535-4F90-4786-9AB8-B242AA4B6354

P356

Q34702127-7FB533F8-6538-4938-8913-1C0CC8D05961

P407

Q34702127-6FFFF43D-3182-4B68-92E5-0F26B9C7B608

P433

Q34702127-B95DF084-571E-49B4-9D62-742910F182DD

P478

Q34702127-2E5A1FB7-B1A8-4FD0-95D9-F3DFA6FCC963

P50

Q34702127-066499DD-2708-4953-BDD0-4D17FE62CA77

Q34702127-26EFDDA3-6C58-4629-A8DF-E13E117E8976

Q34702127-30D8F679-32C0-4652-92E8-BB9292B25EB3

Q34702127-3C3277ED-662F-450C-BB65-3892AA1E1841

Q34702127-4D403214-E79D-442A-96DD-8F357D836D8B

Q34702127-782A92F2-0BCB-42C7-A67D-A5847DA523A1

Q34702127-A3A7F728-A47D-4617-A774-FB19EDB855E6

Q34702127-E9006EBD-D8E5-4590-AFCF-B8D8836D4714

P577

Q34702127-D070BB68-E5D8-4B92-9CC7-56C38BCCFE27

P5875

Q34702127-46899A70-E11B-4438-BAA7-BA38098AA1E1

P698

Q34702127-9C2CDEA5-CA0B-42D9-984D-538A61383D23

P921

Q34702127-01B21BE4-193B-48FF-A340-1E00FD88AC10

Q34702127-C3800A28-0826-4D38-A80E-56524957411F

Q34702127-EB6CEECE-B4AE-498A-B0B0-40029FB5816D

P932

Q34702127-9AD0020B-ED83-4D9B-B468-D20BD0A42A6C

P356

JOURNAL.PONE.0062885

P1433

P1476

Molecular characterization of ...... patitis--a longitudinal study.

@en

P2093

Angel Mei-Ling Chim

http://www.w3.org/2001/XMLSchema#string

Chi-Hang Tse

http://www.w3.org/2001/XMLSchema#string

Hoi-Shan Kwan

http://www.w3.org/2001/XMLSchema#string

Jun Yu

http://www.w3.org/2001/XMLSchema#string

Patrick Tik-Wan Law

http://www.w3.org/2001/XMLSchema#string

P2860

A human gut microbial gene catalogue established by metagenomic sequencing

Metagenomic analysis of the human distal gut microbiome

Infernal 1.0: inference of RNA alignments

A core gut microbiome in obese and lean twins

An obesity-associated gut microbiome with increased capacity for energy harvest

Microbial ecology: human gut microbes associated with obesity

The gut microbiota as an environmental factor that regulates fat storage

High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study

Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst

FastTree 2--approximately maximum-likelihood trees for large alignments

P304

e62885

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0062885

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Tommy Tsan-Yuk Lam

Vincent Wai-Sun Wong

Henry Lik-Yuen Chan

Joseph Jao-Yiu Sung

Grace Lai-Hung Wong

David Ka-Wai Yeung

Winnie Chiu-Wing Chu

Winnie Chiu-Wing Chu

P577

2013-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236604555

http://www.w3.org/2001/XMLSchema#string

P698

23638162

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

P932

3636208

http://www.w3.org/2001/XMLSchema#string